The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1026
Healthcare Clients
3620
Total Healthcare Names
16
Obesity Names
Animal Health - 24
Antibiotic - 96
Antifungal - 26
Antiviral - 96
Antiviral/HIV - 48
Biologic Suffix - 26
Cardiovascular - 186
Class Name - 9
Clinical Trial Name - 74
Corporate Identity - 113
COVID-19 - 25
Dermatology - 127
Division Identity - 16
Endocrinology - 172
Gastrointestinal - 104
Hematology - 133
Identity Research - 15
Immunology - 202
Medical Device - 241
Men's Health - 11
Metabolic Disorders - 55
Musculoskeletal - 32
Nephrology - 25
Neurology - 308
Nutritional Agent - 48
Obesity - 16
Oncology - 649
Ophthalmology - 118
Oral Care - 8
Pain & Inflammation - 150
Product Identity - 7
Program Name - 15
Respiratory - 177
Service Name - 16
Tagline - 10
Technology Name - 18
Urology - 24
USAN/INN - 1145
Vaccine - 85
Website - 16
Women's Health - 132

* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
GLAXOSMITHKLINEALLI Obesity
JANSSENefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity